Their study found that insulin-like grown factor 2 mRNA-binding protein 2 (RBP-IGF2BP2) and FBXL19-AS1 were overexpressed in glioma microvessel and glioma endothelial cells (GECs). The gene discussed is FBXL19; the disease is central nervous system cancer.